Journal
ANTIBIOTICS-BASEL
Volume 9, Issue 8, Pages -Publisher
MDPI
DOI: 10.3390/antibiotics9080462
Keywords
short chain fatty acids (SCFA); inflammatory bowel disease (IBD); Crohn's disease (CD); adherent invasive E. coli (AIEC); colorectal cancer (CRC); pathosymbiont; gene expression; motility; invasion; host
Categories
Funding
- Jill Roberts Center for IBD, Weill Cornell Medicine, New York, NY, USA
Ask authors/readers for more resources
Short chain fatty acids (SCFA), principally acetate, propionate, and butyrate, are produced by fermentation of dietary fibers by the gut microbiota. SCFA regulate the growth and virulence of enteric pathogens, such as enterohemorrhagic E. coli (EHEC), Klebsiella and Salmonella. We sought to investigate the impact of SCFA on growth and virulence of pathosymbiontE. coliassociated with inflammatory bowel disease (IBD) and colorectal cancer (CRC), and their role in regulating host responses to bacterial infection in vitro. We found that under ileal conditions (pH=7.4; 12 mM total SCFA), SCFA significantly (p<0.05) potentiate the growth and motility of pathosymbiontE. coli. However, under colonic conditions (pH=6.5; 65 to 123 mM total SCFA), SCFA significantly (p<0.05) inhibit growth in a pH dependent fashion (up to 60%), and down-regulate virulence gene expression (e.g., fliC, fimH, htrA, chuA, pks). Functional analysis reveals that colonic SCFA significantly (p<0.05) inhibitE. colimotility (up to 95%), infectivity (up to 60%), and type 1 fimbria-mediated agglutination (up to 50%). In addition, SCFA significantly (p<0.05) inhibit the activation of NF-kappa B, and IL-8 production by epithelial cells. Our findings provide novel insights on the role of the regional chemical microenvironment in regulating the growth and virulence of pathosymbiont E. coli and opportunities for therapeutic intervention.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available